In our previous study [8], we showed semen exosome miRNA signatures that combined with blood Prostate specific antigen (PSA) concentration, can be used as molecular biomarkers with the potential to improve PCa diagnosis efficiency of PSA. The gene discussed is KLK3; the disease is posterior cortical atrophy.